Deepak Fertilisers & Petrochemicals Corp Ltd (DEEPAKFERT)
🎯 Key Takeaways
- Deepak Fertilisers & Petrochemicals Corp Ltd is in a strategic growth phase, transitioning from commodity-driven margins to premium specialty chemicals, supported by major capex projects nearing completion. Management is focused on value-based pricing and operational excellence to drive profitability, despite near-term headwinds in crop nutrition.
- Revenue grew 8.1% QoQ to ₹3,256 in Q1FY27.
- ⚠️ Monsoon delays and subsidy delays continue to impact crop nutrition segment profitability, as highlighted in management commentary.
- Market Cap
- ₹17,067
- P/E Ratio
- 17.3
- P/B Ratio
- 2.49
- ROE
- 14.4%
- ROCE
- 13.6%
- Debt/Equity
- 0.80
- Div Yield
- 0.74%
- Promoter
- 45.6%
📖 The Story
Deepak Fertilisers & Petrochemicals Corp Ltd is in a strategic growth phase, transitioning from commodity-driven margins to premium specialty chemicals, supported by major capex projects nearing completion. Management is focused on value-based pricing and operational excellence to drive profitability, despite near-term headwinds in crop nutrition. The company maintains a healthy balance sheet and strong governance, with consistent shareholder support.
📰 What's Happening
In Q1 FY27, Deepak Fertilisers reported a 101% YoY surge in net profit to ₹6834 lakhs, driven by 22% YoY revenue growth to [amount not verified] and improved margins, particularly in specialty chemicals (43% contribution). Management highlighted progress on the Dahej Nitric Acid and Gopalpur TAN projects, targeting commissioning by end of Q2 FY27, and reaffirmed its strategic focus on premiumization amid elevated FGAN prices. The company also reappointed P G Bhagwat LLP as tax auditor for FY27. Earlier, at the 46th AGM on 1 September 2026, it approved FY26 results with consolidated PAT of ₹740 crores, reaffirmed a ₹4,650 Cr capex plan, and inducted two new independent directors, including Purvi Mehta Bhatt as the first woman independent director.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 3,006 | 2,830 | 3,011 | 3,256 |
| Operating Profit | 357 | 245 | 248 | 740 |
| OPM % | 11.9% | 8.7% | 8.3% | 22.7% |
| Net Profit | 214 | 141 | 139 | 490 |
| EPS | ₹16.89 | ₹11.21 | ₹11.04 | ₹38.82 |
The company's financial trajectory shows a clear inflection point: revenue grew from ₹2,830 crores (Dec 2025) to ₹3,256 crores (Jun 2026), while operating profit jumped from ₹245 crores to ₹740 crores, pushing OPM from 8.7% to 22.7%. Net profit rose sharply from ₹141 crores (Dec 2025) to ₹490 crores (Jun 2026), reflecting margin expansion from operational leverage and specialty product mix. This growth aligns with management's narrative of project commissioning progress and value-based pricing, though crop nutrition faced monsoon-related delays. The steep rise in OPM from 8.3% (Mar 2026) to 22.7% (Jun 2026) underscores the impact of scale and project milestones.
🔮 Management Outlook & What's Next
Management expressed confidence in sustained momentum, citing elevated FGAN prices and a supportive market environment for value-based pricing. They reaffirmed the commissioning of the Dahej Nitric Acid and Gopalpur TAN projects by H2-FY27, which are central to expanding specialty chemical capacity. Capex remains within approved limits, and the strategic focus continues on premiumization and integrated value chain growth. No formal forward guidance beyond project timelines was provided, but operational updates in filings suggest near-term catalysts tied to project completions.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 126 | 126 | 126 | 126 |
| Reserves | 6,110 | 5,551 | 6,718 | 6,388 |
| Borrowings | 4,152 | 3,776 | 5,486 | 4,440 |
| Total Liabilities | 13,148 | 12,242 | 16,488 | 15,026 |
| Fixed Assets | 6,230 | 6,174 | 5,857 | 6,144 |
| Investments | 186 | 125 | 434 | 589 |
| Total Assets | 13,148 | 12,242 | 16,488 | 15,026 |
The balance sheet reflects a deliberate capital allocation strategy: total assets grew from ₹13,148 crores (Mar 2025) to ₹16,488 crores (Mar 2026), driven by rising borrowings (₹5,486 crores) and reserves. While equity remains stable at ₹126 crores, reserves increased from ₹6,110 to ₹6,718 crores, indicating retained earnings are being reinvested. Borrowings rose significantly, suggesting active financing of the ₹4,650 Cr capex plan for specialty projects. Despite higher debt, the debt-to-equity ratio of 0.80 remains manageable, with no signs of distress, pointing to disciplined leverage for growth.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +206 |
| Investing | -1,559 |
| Financing | +1,376 |
| Net Cash Flow | +24 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 45.6% | 45.6% | 45.6% | 45.6% |
| FII | 10.9% | 10.3% | 10.3% | 10.0% |
| DII | 12.6% | 13.2% | 13.2% | 14.7% |
| Public | 24.1% | 23.9% | 24.3% | 23.2% |
| # Shareholders | 2,12,266 | 1,99,706 | 1,96,724 | 1,78,847 |
Institutional investor behavior shows mixed trends: FII holding declined slightly from 10.95% (Q2FY26) to 10.02% (Q1FY27), while DII increased from 12.6% to 14.69%, indicating growing domestic institutional confidence. Promoter holding remained stable at 45.63% across quarters. The rise in shareholder count from 1,78,847 (Q1FY27) to 2,12,266 (Q2FY26) suggests broadening retail interest. No pledging or significant exits were reported, and the consistent approval of governance matters at the AGM reflects stable institutional backing.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.50 L Cr | 56.5 | 33.4% | — | 0.01 |
| SRF | 73,336 | 33.9 | 15.6% | — | 0.36 |
| LINDEINDIA | 54,023 | 98.9 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,430 | 79.2 | 9.6% | — | 0.34 |
| NAVINFLUOR | 42,306 | 53.5 | 22.2% | — | 0.31 |
| GODREJIND | 34,967 | 29.8 | 9.2% | — | 4.57 |
| HSCL | 34,188 | 42.5 | 20.7% | — | 0.16 |
| AETHER | 22,546 | 95.6 | 13.8% | — | 0.08 |
| DEEPAKNTR | 20,882 | 26.6 | 15.3% | — | 0.26 |
| CASTROLIND | 19,817 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Monsoon delays and subsidy delays continue to impact crop nutrition segment profitability, as highlighted in management commentary. 2. Repeated SEBI disclosure lapses — including the recent administrative warning — raise concerns about governance reliability and compliance rigor, potentially affecting investor sentiment. 3. Execution risk around Dahej and Gopalpur project timelines; delays could disrupt the specialty chemicals growth trajectory. 4. Input cost volatility in natural gas and raw materials could pressure margins if pricing power erodes.
📋 Recent Filings
- 🔴 Announcement2026-10-01Deepak Fertilisers & Petrochemicals Corp Ltd received an administrative warning from SEBI for failing to disclose investments in subsidiaries and cert…
- 🔴 Announcement2026-09-28Deepak Fertilisers announced the resignation of Vice President Legal, Company Secretary & Compliance Officer Rabindra Purohit effective September 28, …
- Announcement2026-09-28Deepak Fertilisers & Petrochemicals Corp Ltd announced that its trading window will close on 1 October 2026 for all designated persons and their immed…
- 🟡 voting results2026-09-02Deepak Fertilisers & Petrochemicals Corp Ltd held its 46th AGM on 1 September 2026 via video conference, with all six resolutions passed via remote e-…
- 🟡 Board Meeting2026-09-01Deepak Fertilisers & Petrochemicals Corp Ltd held its 46th AGM on 1 September 2026, approving FY2025-26 results with consolidated revenue of **₹11,500…
- 🔴 Announcement2026-09-01Deepak Fertilisers announced a management reshuffle effective September 1, 2026, creating two new manufacturing leadership roles and appointing Mr. Am…
- 🔴 annual report2026-08-11Deepak Fertilizers announced that shareholders without registered email addresses received a letter with a web-link and QR code to access the FY2025-2…
- 🔴 annual report2026-08-09Deepak Fertilizers announced its 46th Annual General Meeting on 1 September 2026 via video conference, seeking shareholder approval for adopting audit…
- Announcement2026-08-06Deepak Fertilizers reported Q1 FY27 revenue of **₹3,256 crores** (+22% YoY) and net profit of **₹490 crores** (+101% YoY), driven by strong operating …
- 🔴 Financial Results2026-07-30Deepak Fertilizers reported Q1 FY27 net profit of **₹6834 lakhs** ([amount not verified]), up **101% YoY** and **252% QoQ**, driven by strong revenue …
🧠 Analyst's Read
Deepak Fertilisers is executing a clear specialty chemicals transition with strong operational momentum, but near-term profitability may remain volatile due to monsoon and subsidy dependencies in crop nutrition. Investors should monitor project commissioning timelines and clarity on margin sustainability beyond FGAN price tailwinds. Governance improvements are needed to mitigate reputational risks from repeated disclosure oversights.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DEEPAKFERT files new disclosures
Track DEEPAKFERT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DEEPAKFERT — FreeFree account · 2 AI queries/day